Immunomedics Inc (NASDAQ:IMMU) - Share price - Overview

Stock Report

Immunomedics Inc IMMU

Last Price
$22.58

Day Change
0.01|0.04%

As of 24/05/2018
18:12:37 EDT | USD
Minimum 15 Minutes Delay.

Last Close22.57
Day Range22.32 - 23.18
Mkt Cap3.78Bil
52-Wk Range7.17 - 23.18
Yield %-
ISINUS4529071080
Volume1,871,850
P/E-14.29
P/S1,250.00
P/CF-27.98

Share Price

Financials
201520162017
More ...
Income Statement
Revenue5.653.233.09
Operating Income-46.22-59.01-79.15
Net Income-48.00-59.04-153.21
Basic EPS-0.51-0.62-1.47
Avg. Diluted Shares Outstanding9395105
Balance Sheet
Current Assets103.4952.95157.30
Non Current Assets2.294.005.28
Total Assets105.7856.95162.57
Current Liabilities12.0815.42122.24
Total Liabilities---
Total Equity-3.91-56.82-58.69
Cash Flow
Operating Cash Flow-39.00-48.46-62.25
Capital Expenditure-0.92-2.23-1.84
Free Cash Flow-39.92-50.69-64.09

In millions, except "Basic EPS". Currency is USD.

Company Profile

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

June

Employees

138
Key Stats
More ...
Price/Earning TTM-14.28
Price/Book52.00
Price/Sales TTM858.17
Rev Growth (3 year avg)-30.08
EPS Growth (3 year avg)-
Operating Margin % TTM-2,560.44
Net Margin % TTM-4,956.12
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.